The de-linkage of R&D costs and drug prices through the Prize Fund for HIV/AIDS will cost less, expand access, accelerate and improve innovation, and replace an incentive system that is expensive, inefficient and unsustainable. James Love’s testimony before Senate Subcommittee on Primary Health and Aging.
|By: James Love Tuesday May 15, 2012 7:01 am|
|By: Jon Walker Monday October 24, 2011 12:10 pm|
A poll of Massachusetts residents found that regular people in Massachusetts understand why their health care is so extremely expensive. It’s because they have to pay too much for drugs, insurance and hospital care, compared to what other nations pay.
|By: Jon Walker Monday June 20, 2011 12:30 pm|
Looking at how the incentives in our health care market are currently set up, there is little reason to hope the “market” will magically come up with innovations to reduce our national health care spending. It is no surprise given looking at our structural innovation issues that for decades we have seen health care cost grow so rapidly.